MURDOCK TERRY L - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 18, 2024, MURDOCK TERRY L's relationship to G1 Therapeutics, Inc. (GTHX) is Officer (Chief Operating Officer), and currently has 145,912 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GTHX insiders.

Data Source: SEC.
MURDOCK TERRY L - Insider Non-Derivative Transactions of GTHX Common Stock
MURDOCK TERRY L - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 19, 2024 U -- (Common Stock) 21150 0 0
Sep 19, 2024 Disposition -- (Common Stock) 124762 0 21150
Sep 19, 2024 Acquisition -- (Common Stock) 17900 0 145912
Jul 6, 2024 Sell -- (Common Stock) 2475 2.51 128012
Jul 2, 2024 Acquisition -- (Common Stock) 35000 0 130487
May 14, 2024 Sell -- (Common Stock) 8151 4.79 95487
Jan 5, 2024 Sell -- (Common Stock) 721 2.94 103638
Jan 4, 2024 Sell -- (Common Stock) 2261 3.12 104359
Jan 4, 2024 Sell -- (Common Stock) 758 3.12 106620
Jan 4, 2024 Acquisition -- (Common Stock) 37300 0 107378
Jul 6, 2023 Sell -- (Common Stock) 1361 2.45 70078
May 11, 2023 Acquisition -- (Common Stock) 35000 0 71439
Jan 6, 2023 Sell -- (Common Stock) 729 5.41 36439
Jan 5, 2023 Sell -- (Common Stock) 1639 5.58 37168
Jan 4, 2023 Acquisition -- (Common Stock) 17900 0 38807